leisure time -WSS

leisure time

author：knowledge 2025-09-27 19:38:04 - browse：5

Illustration of a teal cancer cell. -- health coverage from STAT — Illustration of a teal cancer cell. Adobe

Sana Biotechnology, a startup that just a couple of years ago raised over $1 billion off a grand plan to create a portfolio of powerful medicines, said Tuesday it would lay off nearly a third of its employees and de-prioritize one of its most ambitious programs as it looks to save money.

The layoffs are Sana’s second round of cuts in less than a year. It laid off 15% of staff last November after axing another program.

Tuesday’s move pushed back a program focused on turning a patient’s own immune cells into cancer-killing assassins or curing blood disorders such as sickle cell with just an IV infusion. Known as in vivo reprogramming, it was originally the company’s central focus and would have amounted to a monumental breakthrough.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： The best solution to the drug shortages problem

hotspot

WSS

What to know about Virgin Galactic's 1st mission taking paying customers to space

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

NIH trials fail to test meaningful long Covid therapies, experts say

Hospitals owned by private equity see complications spike 25%

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Virtual care provider acquires bankrupt Pear's prescription apps

entertainment

leisure time

explore

Virginia high school admissions case could be legal follow

HCA sued by state AG for quality issues at Mission Health

After affirmative action ruling, medical educators look to 'holistic review'

Anavex keeps shifting the goalposts in its clinical trials

Anesthesiologist group: stop taking Ozempic before surgery

South Korea throws huge K

Novavax promises a turnaround & Lilly roils the obesity market

HCA sued by state AG for quality issues at Mission Health

Duchenne breakthrough therapy leaves behind pioneering families

American woman, child freed after being kidnapped in Haiti last month

focus

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

CRISPR gene editing developments we’re watching in 2024

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Friends ask where James Watson's attitudes about race came from

The best solution to the drug shortages problem

Hospitals owned by private equity see complications spike 25%

hotspot

focus

knowledge

explore